Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
129.69
-3.53 (-2.65%)
At close: May 29, 2026, 4:00 PM EDT
128.11
-1.58 (-1.22%)
After-hours: May 29, 2026, 7:58 PM EDT
Guardant Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 989.29 | 378.2 | 525.54 | 1,134 | 141.65 | 492.2 |
Short-Term Investments | 113.47 | 823.4 | 314.44 | 35.1 | 869.58 | 440.55 |
Cash & Short-Term Investments | 1,103 | 1,202 | 839.98 | 1,169 | 1,011 | 932.75 |
Cash Growth | 57.86% | 43.05% | -28.12% | 15.57% | 8.41% | -48.03% |
Accounts Receivable | 137.4 | 137.85 | 110.25 | 88.78 | 97.26 | 97.65 |
Inventory | 83.85 | 85.88 | 71.08 | 61.95 | 51.6 | 30.67 |
Other Current Assets | 43.49 | 40.72 | 33.8 | 27.74 | 31.51 | 53.05 |
Total Current Assets | 1,368 | 1,466 | 1,055 | 1,347 | 1,192 | 1,114 |
Net Property, Plant & Equipment | 303.94 | 304.76 | 279.08 | 302.71 | 341.92 | 313.9 |
Other Intangible Assets | 25.54 | 25.92 | 6.76 | 8.98 | 11.73 | 14.21 |
Goodwill | 77.26 | 77.26 | 3.29 | 3.29 | 3.29 | 3.29 |
Long-Term Investments | - | - | - | - | - | 698.03 |
Other Long-Term Assets | 141.05 | 139.67 | 141.37 | 124.33 | 61.45 | 60.94 |
Total Assets | 1,915 | 2,014 | 1,486 | 1,786 | 1,610 | 2,205 |
Accounts Payable | 75.03 | 54.44 | 38.55 | 51.74 | 175.82 | 105.36 |
Accrued Expenses | 169.34 | 197.54 | 151.56 | 136.21 | - | - |
Unearned Revenue | 47.77 | 50.75 | 35.47 | 17.97 | 17.4 | 11.33 |
Other Current Liabilities | - | - | - | - | - | 78 |
Total Current Liabilities | 292.15 | 302.73 | 225.58 | 205.92 | 193.22 | 194.69 |
Long-Term Debt | 1,503 | 1,504 | 1,143 | 1,140 | 1,137 | 1,135 |
Long-Term Leases | 173.06 | 178.46 | 164.29 | 185.85 | 210.02 | 226.05 |
Other Long-Term Liabilities | 127.69 | 127.77 | 92.83 | 96.01 | 9.18 | 3.93 |
Total Long-Term Liabilities | 1,804 | 1,810 | 1,400 | 1,422 | 1,357 | 1,365 |
Total Liabilities | 2,096 | 2,113 | 1,625 | 1,628 | 1,550 | 1,559 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 2,931 | 2,900 | 2,444 | 2,304 | 1,742 | 1,658 |
Accumulated Other Comprehensive Income | -5.15 | -4.85 | -5.2 | -3.68 | -19.52 | -4.76 |
Retained Earnings | -3,107 | -2,995 | -2,578 | -2,142 | -1,662 | -1,008 |
Total Common Shareholders' Equity | -181.07 | -99.31 | -139.65 | 158.68 | 60.18 | 645.01 |
Shareholders' Equity | -181.07 | -99.31 | -139.65 | 158.68 | 60.18 | 645.01 |
Total Liabilities & Equity | 1,915 | 2,014 | 1,486 | 1,786 | 1,610 | 2,205 |
Total Debt | 1,677 | 1,682 | 1,307 | 1,326 | 1,347 | 1,361 |
Net Cash (Debt) | -573.77 | -480.87 | -466.86 | -157.18 | -336.18 | -428.13 |
Net Cash Per Share | -4.51 | -3.83 | -3.80 | -1.40 | -3.29 | -4.23 |
Book Value | -181.07 | -99.31 | -139.65 | 158.68 | 60.18 | 645.01 |
Book Value Per Share | -1.42 | -0.79 | -1.14 | 1.42 | 0.59 | 6.37 |
Tangible Book Value | -283.87 | -202.49 | -149.7 | 146.42 | 45.16 | 627.51 |
Tangible Book Value Per Share | -2.23 | -1.62 | -1.22 | 1.31 | 0.44 | 6.19 |